Cancer biomarkers: can we turn recent failures into success? (Q34176379)

31 July 2017

Cancer biomarkers: can we turn recent failures into success? (English)

1 reference

31 July 2017

0 references

Eleftherios P. Diamandis

series ordinal

1

object named as

Eleftherios P Diamandis

1 reference

PubMed ID

20705936

31 July 2017

language of work or name

English

0 references

publication date

12 August 2010

1 reference

Journal of the National Cancer Institute

31 July 2017

1 reference

31 July 2017

102

1 reference

31 July 2017

1462-1467

1 reference

31 July 2017

19

1 reference

Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Next-generation sequencing: a new revolution in molecular diagnostics?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

EPCA-2: a highly specific serum marker for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Differential exoprotease activities confer tumor-specific serum peptidome patterns

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Serum protein markers for early detection of ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Osteopontin as a potential diagnostic biomarker for ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Use of proteomic patterns in serum to identify ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Phases of biomarker development for early detection of cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Screening for prostate cancer--the controversy that refuses to die.

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Plasma lysophosphatidic acid concentration and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Ovarian cancer early detection claims are biased.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2950166

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers

28 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

POINT: EPCA-2: A promising new serum biomarker for prostatic carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

Early Prostate Cancer Antigen-2: A Controversial Prostate Cancer Biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ306

NMR--another cancer-test disappointment

21 January 2018

1 reference

12 December 2020

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

12 December 2020

Microarrays and molecular research: noise discovery?

1 reference

12 December 2020

Prediction of cancer outcome with microarrays: a multiple random validation strategy

1 reference

12 December 2020

Selective reporting biases in cancer prognostic factor studies

1 reference

12 December 2020

Diagnostic markers for early detection of ovarian cancer

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJQ306

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

20705936